Cargando…

Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration

SIMPLE SUMMARY: Cell migration is the main obstacle to the treatment of highly invasive brain cancer glioblastoma multiforme (GBM). We investigated in vitro the potential role of two solute carrier proteins (SLCs), SLC5A1 and SLC5A3, and their respective substrates, glucose and inositol, in GBM cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brosch, Philippa K., Korsa, Tessa, Taban, Danush, Eiring, Patrick, Hildebrand, Sascha, Neubauer, Julia, Zimmermann, Heiko, Sauer, Markus, Shirakashi, Ryo, Djuzenova, Cholpon S., Sisario, Dmitri, Sukhorukov, Vladimir L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738886/ https://www.ncbi.nlm.nih.gov/pubmed/36497276 http://dx.doi.org/10.3390/cancers14235794

Ejemplares similares

Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration. Cancers 2022, 14, 5794
por: Brosch, Philippa K., et al.
Publicado: (2023)

Contraction of the rigor actomyosin complex drives bulk hemoglobin expulsion from hemolyzing erythrocytes
por: Shirakashi, Ryo, et al.
Publicado: (2022)

FocAn: automated 3D analysis of DNA repair foci in image stacks acquired by confocal fluorescence microscopy
por: Memmel, Simon, et al.
Publicado: (2020)

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
por: Djuzenova, Cholpon S., et al.
Publicado: (2021)

Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells
por: Djuzenova, Cholpon S., et al.
Publicado: (2019)

Hypotonic Activation of the Myo-Inositol Transporter SLC5A3 in HEK293 Cells Probed by Cell Volumetry, Confocal and Super-Resolution Microscopy
por: Andronic, Joseph, et al.
Publicado: (2015)

MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule
por: Grabenbauer, Felix, et al.
Publicado: (2018)

Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities
por: Memmel, Simon, et al.
Publicado: (2017)

SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia
por: Wei, Yiliang, et al.
Publicado: (2022)

Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule
por: Djuzenova, Cholpon S., et al.
Publicado: (2016)

Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis
por: De Paepe, Boel, et al.
Publicado: (2020)

SLC-2000: a luminosity upgrade for the SLC
por: Breidenbach, M, et al.
Publicado: (1996)

Beam-beam simulations with non-gaussian distributions for SLC and SLC-2000
por: Bane, Karl Leopold Freitag, et al.
Publicado: (1998)

Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia
por: Deng, Xiangdong, et al.
Publicado: (2008)

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
por: Nachef, Marianna, et al.
Publicado: (2021)

The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth
por: Cui, Zihan, et al.
Publicado: (2022)

Putative roles of SLC7A5 (LAT1) transporter in pain
por: Alles, Sascha R.A., et al.
Publicado: (2020)

Different Effects of Valproic Acid on SLC12A2, SLC12A5 and SLC5A8 Gene Expression in Pediatric Glioblastoma Cells as an Approach to Personalised Therapy
por: Damanskienė, Eligija, et al.
Publicado: (2022)

Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6)
por: Bhutia, Yangzom D., et al.
Publicado: (2022)

Slc7a5 regulation of neural development
por: Sokolov, Aidan M., et al.
Publicado: (2021)

mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas
por: Suh, Sunghwan, et al.
Publicado: (2018)

Emittance dilution by ions in the SLC arcs
por: Emma, P, et al.
Publicado: (1994)

Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma
por: Tina, E., et al.
Publicado: (2018)

Impact of Genetic Polymorphisms of SLC2A2, SLC2A5, and KHK on Metabolic Phenotypes in Hypertensive Individuals
por: Le, MyPhuong T., et al.
Publicado: (2013)

SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine–Glycine–One-Carbon Pathways in Cancer
por: Sniegowski, Tyler, et al.
Publicado: (2021)

The citrate transporters SLC13A5 and SLC25A1 elicit different metabolic responses and phenotypes in the mouse
por: Fernandez-Fuente, Gonzalo, et al.
Publicado: (2023)

Molecular Mechanisms of the SLC13A5 Gene Transcription
por: Li, Zhihui, et al.
Publicado: (2021)

Status of the SLC
por: Seeman, J T, et al.
Publicado: (1987)

Polarization at SLC
por: Swartz, M L
Publicado: (1988)

Simulation studies of the SLC bunch compressor (RTL)
por: Zimmermann, Frank
Publicado: (1996)

Association Study of the SLC1A2 (rs4354668), SLC6A9 (rs2486001), and SLC6A5 (rs2000959) Polymorphisms in Major Depressive Disorder
por: Rodek, Patryk, et al.
Publicado: (2022)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Novel mutations in SLC6A5 with benign course in hyperekplexia
por: Dafsari, Hormos Salimi, et al.
Publicado: (2019)

Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5
por: Chen, Fangfang, et al.
Publicado: (2023)

SLC5A3 is important for cervical cancer cell growth
por: Li, Li, et al.
Publicado: (2023)

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis
por: Chen, Yan-Jie, et al.
Publicado: (2022)

Collimator wake fields in the SLC final focus
por: Zimmermann, Frank, et al.
Publicado: (1996)

Limitations of interaction Spot-size tuning at the SLC
por: Emma, P, et al.
Publicado: (1998)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

Metabolic adaptations to hypoxia in the neonatal mouse forebrain can occur independently of the transporters SLC7A5 and SLC3A2
por: Fitzgerald, Eamon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_51rb09anmik3coas7rpq9mqre4